← Back to Discover
BVF INC/IL
Period ended Jun 30, 2026 · Latest filing Aug 14, 2026
These quarterly holdings are delayed and may not include all assets or short positions.
Values are from the reporting date, not current prices or purchase costs.
The same security may appear in multiple rows.
Source: SEC
Reported portfolio value
Quarter-end reported holdings; not current value or investment performance.
View reported values
- Jun 30, 2026: $3,910,995,502
More quarters will appear as history becomes available.
Top holdings
Top 10 at Jun 30, 2026. Matching entries are combined; security classes and options remain separate. Shares exclude principal amounts; option shares reflect the reported underlying amount.
View top holdings values
- REVOLUTION MEDICINES INC · COM · 76155X100 · shares: $555,315,165
- KYMERA THERAPEUTICS INC · COM · 501575104 · shares: $444,008,203
- XOMA ROYALTY CORPORATION · COM NEW · 98419J206 · shares: $322,715,378
- MOONLAKE IMMUNOTHERAPEUTICS · CLASS A ORD · 61559X104 · shares: $311,544,999
- GH RESEARCH PLC · ORDINARY SHARES · G3855L106 · shares: $232,516,247
- STRUCTURE THERAPEUTICS INC · SPONSORED ADS · 86366E106 · shares: $180,697,390
- NEKTAR THERAPEUTICS · COM NEW · 640268306 · shares: $166,920,946
- MIRUM PHARMACEUTICALS INC · COM · 604749101 · shares: $123,629,081
- XENCOR INC · COM · 98401F105 · shares: $114,852,892
- ALKERMES PLC · SHS · G01767105 · shares: $112,895,716
Reported holdings
44 reported entries| Issuer | Class | CUSIP | Type | Shares / principal | Reported value (USD) |
|---|---|---|---|---|---|
| REVOLUTION MEDICINES INC | COM | 76155X100 | — | 2,965,160 shares | $555,315,165 |
| KYMERA THERAPEUTICS INC | COM | 501575104 | — | 3,872,052 shares | $444,008,203 |
| XOMA ROYALTY CORPORATION | COM NEW | 98419J206 | — | 7,593,303 shares | $322,715,378 |
| MOONLAKE IMMUNOTHERAPEUTICS | CLASS A ORD | 61559X104 | — | 16,001,284 shares | $311,544,999 |
| GH RESEARCH PLC | ORDINARY SHARES | G3855L106 | — | 8,650,158 shares | $232,516,247 |
| STRUCTURE THERAPEUTICS INC | SPONSORED ADS | 86366E106 | — | 3,366,823 shares | $180,697,390 |
| NEKTAR THERAPEUTICS | COM NEW | 640268306 | — | 2,391,075 shares | $166,920,946 |
| MIRUM PHARMACEUTICALS INC | COM | 604749101 | — | 1,056,027 shares | $123,629,081 |
| XENCOR INC | COM | 98401F105 | — | 7,133,720 shares | $114,852,892 |
| ALKERMES PLC | SHS | G01767105 | — | 2,154,704 shares | $112,895,716 |
| MONTE ROSA THERAPEUTICS INC | COM | 61225M102 | — | 4,460,886 shares | $107,953,441 |
| CULLINAN THERAPEUTICS INC | COM | 230031106 | — | 5,750,683 shares | $104,719,937 |
| PALVELLA THERAPEUTICS INC NE | COM | 697947109 | — | 672,789 shares | $102,815,615 |
| ZYMEWORKS INC | COM | 98985Y108 | — | 3,649,142 shares | $95,388,572 |
| KURA ONCOLOGY INC | COM | 50127T109 | — | 8,445,769 shares | $92,650,086 |
| DISC MEDICINE INC | COM | 254604101 | — | 1,153,612 shares | $84,375,182 |
| STOKE THERAPEUTICS INC | COM | 86150R107 | — | 2,547,557 shares | $83,356,065 |
| OLEMA PHARMACEUTICALS INC | COM | 68062P106 | — | 5,295,893 shares | $66,251,621 |
| ANNEXON INC | COM | 03589W102 | — | 8,698,173 shares | $49,666,568 |
| CRESCENT BIOPHARMA INC. | COM | G2545C104 | — | 2,748,763 shares | $49,477,734 |
| AC IMMUNE SA | SHS | H00263105 | — | 19,822,436 shares | $47,177,398 |
| TYRA BIOSCIENCES INC | COM | 90240B106 | — | 1,476,196 shares | $47,149,700 |
| SUTRO BIOPHARMA INC | COM SHS | 869367201 | — | 1,251,788 shares | $41,559,362 |
| IMMUNOCORE HLDGS PLC | ADS | 45258D105 | — | 1,294,463 shares | $41,099,200 |
| AVALO THERAPEUTICS INC | COM NEW | 05338F306 | — | 2,075,545 shares | $38,356,072 |
| 4D MOLECULAR THERAPEUTICS IN | COM | 35104E100 | — | 2,879,289 shares | $38,294,544 |
| Q32 BIO INC | COM | 746964105 | — | 2,350,000 shares | $29,939,000 |
| ANTERIS TECHNOLOGIES GLOBAL | COM | 03675P102 | — | 3,000,000 shares | $29,550,000 |
| FOGHORN THERAPEUTICS INC | COM | 344174107 | — | 5,842,000 shares | $28,508,960 |
| ABSCI CORPORATION | COM | 00091E109 | — | 2,361,674 shares | $27,371,802 |
| ELEDON PHARMACEUTICALS INC | COM | 28617K101 | — | 6,293,282 shares | $24,795,531 |
| INVIVYD INC | COM | 00534A102 | — | 28,165,000 shares | $24,571,146 |
| SAGIMET BIOSCIENCES INC | COM SER A | 786700104 | — | 2,500,000 shares | $19,325,000 |
| ONKURE THERAPEUTICS INC | COM CL A | 68277Q105 | — | 3,235,778 shares | $14,755,148 |
| IMMUNIC INC | COM NEW | 4525EP200 | — | 765,295 shares | $11,762,584 |
| X4 PHARMACEUTICALS INC | COM NEW | 98420X202 | — | 2,233,742 shares | $10,431,575 |
| IMAGENEBIO INC | COM | 45175G207 | — | 1,110,002 shares | $6,549,012 |
| TSCAN THERAPEUTICS INC | COM | 89854M101 | — | 5,564,290 shares | $5,453,561 |
| RESEARCH ALLIANCE CORP III | ORD SHS CL A | G75226103 | — | 500,000 shares | $5,350,000 |
| MOLECULAR PARTNERS AG | ADS | 60853G106 | — | 1,353,968 shares | $5,145,078 |
| TENAX THERAPEUTICS INC | COM NEW | 88032L605 | — | 339,549 shares | $4,940,438 |
| ENTERA BIO LTD | SHS | M40527109 | — | 2,425,000 shares | $4,292,250 |
| INVENTIVA SA | ADS | 46124U107 | — | 686,040 shares | $2,593,231 |
| ENGENE THERAPEUTICS | *W EXP 10/31/202 | 29286X119 | — | 945,402 shares | $274,072 |